Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Last Updated: January 28, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Darexaban

Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug Darexaban?

Darexaban is an investigational drug.

There have been 9 clinical trials for Darexaban. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1^st 2010.

The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Astellas Pharma Inc, Astellas Pharma Europe B.V., and [disabled in preview].

Summary for Darexaban

US Patents	0
International Patents	0
US Patent Applications	188
WIPO Patent Applications	129
Japanese Patent Applications	56
Clinical Trial Progress	Phase 1 (2010-01-01)
Vendors	22

Recent Clinical Trials for Darexaban

Title	Sponsor	Phase
To Evaluate if Multiple Doses of Ketoconazole Change the Blood Concentration of YM150 (Darexaban)	Astellas Pharma Inc	Phase 1
To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)	Astellas Pharma Inc	Phase 1
To Evaluate Whether Naproxen and Darexaban (YM150) Interact in Their Effects	Astellas Pharma Inc	Phase 1

See all Darexaban clinical trials

Clinical Trial Summary for Darexaban

Top disease conditions for Darexaban

Top clinical trial sponsors for Darexaban

See all Darexaban clinical trials

US Patents for Darexaban

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign up for a Free Trial
Drugname	Patent Number	Patent Title	Patent Assignee	Estimated Expiration
>Drugname	>Patent Number	>Patent Title	>Patent Assignee	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts

Colorcon

Johnson and Johnson

McKesson

AstraZeneca

Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.